Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels

Context: Dihydromyricetin (DMY) has oxidation resistance, anti-inflammatory and free radical scavenging capabilities. The preventive effects of DMY for vascular hyporeactivity remain unclear. Objective: This study investigates the preventive effects of DMY in vascular hyporeactivity. Materials and m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharm Biol
Egile Nagusiak: Peng, Jin, Zhang, Jian, Zhang, Li, Tian, Yonggang, Li, Yahong, Qiao, Lujun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6130638/
https://ncbi.nlm.nih.gov/pubmed/30003825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13880209.2018.1478430
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak